ZYME
Get informed when a big investor buys or sells
+ FollowOvervalued by 163.1% based on the discounted cash flow analysis.
| Market cap | $2.02 Billion |
|---|---|
| Enterprise Value | $-144,900,215,028.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.08 |
| Beta | 1.17 |
| Outstanding Shares | 72,993,313 |
| P/E Ratio | -13.97 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | 0.03 |
| Enterprise Value to Revenue | -57614.4 |
| Enterprise Value to EBIT | 1.3 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | -0.22 |
| Debt to Equity | 0.4 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 51.37% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 2.28%▼ 91.59% |
|---|---|
| Total Invested | $44.10M▼ 97.54% |
| Investors Holding | 15▼ 193.00% |
No data